These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3451957)

  • 21. Influence of serum protein binding on the pharmacokinetics of quinidine in normal and anuric rats.
    Fremstad D; Jacobsen S; Lunde KM
    Acta Pharmacol Toxicol (Copenh); 1977 Aug; 41(2):161-76. PubMed ID: 579055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of quinidine and cimetidine on the methamphetamine level in the rat brain.
    Suzuki T; Chiang HJ; Misawa M
    Jpn J Pharmacol; 1987 Jan; 43(1):103-6. PubMed ID: 3573415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of phenobarbital and cimetidine on the elimination kinetics and distribution in the heart and liver of propranolol in rats with acute and chronic inflammations].
    Lutsevich AN; Reshet'ko OV; Bogoslovskaia SI
    Eksp Klin Farmakol; 1996; 59(3):47-52. PubMed ID: 8974585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites.
    Yu VC; de Lamirande E; Horning MG; Pang KS
    Drug Metab Dispos; 1982; 10(6):568-72. PubMed ID: 6130901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of plasma protein binding on quinidine kinetics in the rabbit.
    Guentert TW; Oie S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
    Adedoyin A; Aarons L; Houston JB
    Drug Metab Dispos; 1987; 15(1):127-32. PubMed ID: 2881749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between succinylcholine and cimetidine in rats.
    Mishra Y; Ramzan I
    Can J Anaesth; 1992 Apr; 39(4):370-4. PubMed ID: 1314141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition kinetics of quinidine.
    Ueda CT; Hirschfeld DS; Scheinman MM; Rowland M; Williamson BJ; Dzindzio BS
    Clin Pharmacol Ther; 1976 Jan; 19(1):30-6. PubMed ID: 1245091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of phenobarbitone on the distribution and elimination of imipramine in rats.
    Lin TH; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharm Pharmacol; 1985 Oct; 37(10):735-8. PubMed ID: 2867146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of cimetidine on steady state concentration and metabolite formation from antipyrine infused with a rectal osmotic mini pump.
    Teunissen MW; Kleinbloesem CH; de Leede LG; Breimer DD
    Eur J Clin Pharmacol; 1985; 28(6):681-4. PubMed ID: 4065192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lidocaine disposition--sex differences and effects of cimetidine.
    Wing LM; Miners JO; Birkett DJ; Foenander T; Lillywhite K; Wanwimolruk S
    Clin Pharmacol Ther; 1984 May; 35(5):695-701. PubMed ID: 6713782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition of quinidine in the rabbit.
    Guentert TW; Huang JD; Oie S
    J Pharm Sci; 1982 Jul; 71(7):812-5. PubMed ID: 7120069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of orally administered misoprostol and cimetidine on the steady state pharmacokinetics of diazepam and nordiazepam in human volunteers.
    Lima DR; Santos RM; Werneck E; Andrade GN
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):161-70. PubMed ID: 1814733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue distribution and plasma pharmacokinetics of UCN-01 at steady-state and following bolus administration in rats: influence of human alpha1-acid glycoprotein binding.
    Hedaya MA; Daoud SS
    Anticancer Res; 2001; 21(6A):4005-10. PubMed ID: 11911284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased toxicity and reduced clearance of lidocaine by cimetidine.
    Feely J; Wilkinson GR; McAllister CB; Wood AJ
    Ann Intern Med; 1982 May; 96(5):592-4. PubMed ID: 7073151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug interactions between theophylline and H2-antagonists, roxatidine acetate hydrochloride and cimetidine: pharmacokinetic analysis in rats in vivo.
    Nagai N; Furuhata M; Ogata H
    Biol Pharm Bull; 1995 Nov; 18(11):1610-3. PubMed ID: 8593491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentration-time effects of quinidine disposition kinetics in rhesus monkeys.
    Ueda CT; Ballard B; Rowland M
    J Pharmacol Exp Ther; 1977 Mar; 200(3):459-68. PubMed ID: 403278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of quinidine and three of its metabolites in man.
    Rakhit A; Holford NH; Guentert TW; Maloney K; Riegelman S
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):1-21. PubMed ID: 6747817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats.
    Tsuji A; Yoshikawa T; Nishide K; Minami H; Kimura M; Nakashima E; Terasaki T; Miyamoto E; Nightingale CH; Yamana T
    J Pharm Sci; 1983 Nov; 72(11):1239-52. PubMed ID: 6644585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of digoxin, quinidine, and disopyramide interactions in rats utilizing parotid saliva, blood, and other tissues.
    DiGregorio GJ; Piraino AJ; Ruch EK; Basseches PJ
    J Pharm Sci; 1982 Feb; 71(2):211-3. PubMed ID: 7062248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.